Award

SWH - Verulam Chronic Migraine Service 25/27

NHS HERTFORDSHIRE AND WEST ESSEX INTEGRATED CARE BOARD

This public procurement record has 2 releases in its history.

TenderUpdate

27 Dec 2024 at 12:20

Award

12 Dec 2024 at 16:30

Summary of the contracting process

The NHS Hertfordshire and West Essex Integrated Care Board has completed the procurement process for the "SWH - Verulam Chronic Migraine Service 25/27". This procurement falls under the health services category and is aimed at providing clinical management for patients with chronic migraines in the UKH23 region, specifically located in Welwyn Garden City, United Kingdom. The service will commence from 1st April 2025 and run until 31st March 2026, with a potential one-year extension. The contract has been awarded to Neecare Health Care Ltd through Direct Award Process C under the Provider Selection Regime (PSR). This method bypassed the Public Contracts Regulations 2015, focusing primarily on ensuring continuity and quality of service based on the existing provider's performance. Key dates include the contract award date on 27th December 2024, following approvals from the ICB's Strategic Finance and Commissioning Committee. The contract's maximum value is £77,748 per annum, with a total potential value of £155,496 for two years.

This tender offers substantial growth opportunities for health service providers, especially those specialising in chronic migraine management. The existing provider, Neecare Health Care Ltd, delivers botulinum injection therapy for chronic migraine patients compliant with NICE Guidelines, demonstrating expertise in this niche. The service's localised approach reduces need for patients to seek treatment outside the area, enhancing patient satisfaction and operational efficiency. Companies that excel in delivering high-quality, patient-centred care and can align with the Integrated Care System's objectives will find this opportunity beneficial. With a focus on reducing avoidable A&E attendances and integrating seamlessly within the local healthcare network, this contract is ideal for providers committed to innovation, quality, and sustainable healthcare delivery.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

SWH - Verulam Chronic Migraine Service 25/27

Notice Description

The chronic migraine service is provided by Neecare Health Care Ltd<br/>The service undertakes clinical management of chronic migraine for patients who suffer persistent headache.<br/><br/>Neecare chronic migraine service provides clinical intervention for the management of chronic migraine by administering Botulinum injection including regular therapy.<br/><br/>Patients are referred by Neurologist having been diagnosed with Chronic Migraine and meet NICE Guidelines for Botulinum Injection administration.<br/><br/>To confirm, as per the PSR direct award process C, the existing provider is satisfying the existing contract, delivering a good service, meeting all KPIs, with no quality concerns with very good feedback from Clinicians and patients and are likely to satisfy the new contract, The proposed contracting arrangements are not changing from the existing contract.

Lot Information

Lot 1

The Chronic Migraine Clinic provide treatment for patients who suffer from persistence headache of:
* Either tension-type and/or migraine quality and occurs on >=15 days per month for at least 3 months.
* No medication overuse.

A strict referral criterion ensures patients would have to see a Neurologist to be diagnosed with Chronic Migraine and then meets the NICE Guidelines for Botulinum administration.
As such the clinic only accepts referrals from a Neurologist who has diagnosed Chronic Migraine in the patient and who fulfil the NICE criteria.

The clinic maintains close links with the Neurology department at East & North Hertfordshire Trust to receive appropriate support, resources, and education.

The clinic offers face to face and virtual educational sessions about chronic migraine with clearly defined pathway.

The contract is for one year with option to renew for a further one year based on FOT of PS77, 748. Additional information: The contract is for one year with option to renew for a further one year based on FOT of PS77, 748. From April 2025 to March 2027

Options: 1 year with option to extend for a further 1 year

Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 24/12/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04c7ad
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/041565-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£155,496 £100K-£500K

Notice Dates

Publication Date
27 Dec 20241 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
12 Dec 20241 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS HERTFORDSHIRE AND WEST ESSEX INTEGRATED CARE BOARD
Contact Name
Not specified
Contact Email
hweicbhv.procurementteam@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
WELWYN GARDEN CITY
Postcode
AL8 6JL
Post Town
St Albans
Country
England

Major Region (ITL 1)
TLH East (England)
Basic Region (ITL 2)
TLH2 Bedfordshire and Hertfordshire
Small Region (ITL 3)
TLH26 North and East Hertfordshire
Delivery Location
TLH23 Hertfordshire CC

Local Authority
Welwyn Hatfield
Electoral Ward
Handside
Westminster Constituency
Welwyn Hatfield

Supplier Information

Number of Suppliers
1
Supplier Name

VERULAM CHRONIC MIGRAINE INJECTION CLINIC

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-04c7ad-2024-12-27T12:20:47Z",
    "date": "2024-12-27T12:20:47Z",
    "ocid": "ocds-h6vhtk-04c7ad",
    "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 24/12/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR<br/><br/>The business case including the recommendation to award the contract under Provider Selection Regime Process C was approved at the ICB Strategic Finance & Commissioning Committee on the 12/09/2024.<br/><br/>The options paper for this service was presented at the following panels and committees:<br/>* SWH HCP Finance and Commissioning Committee - 22/08/2024<br/>* ICB Commissioning and Contracting Panel - 29/08/2024 (extraordinary meeting)<br/>* Financial Scrutiny Panel - 06/09/2024<br/>* HWE ICB Strategic Finance and Commissioning Committee - 12/09/2024<br/><br/>The were no conflict or potential conflicts declared.<br/><br/>The decision to award this contract in line with Direct Award Process C was based on evaluation against the five required key criteria as follows:<br/>* Quality and Innovation - Assured - HWE ICB are assured that the provider is delivering a safe and effective service as required by the specification and contract they are currently delivering. This criterion was reviewed in line with the Quality Impact Assessment.<br/>* Value - Assured - HWE ICB are assured that the provider is delivering value for money and providing an innovative, sustainable, high-quality service with positive outcomes for patients within the financial envelop.<br/>* Integration, Collaboration and Service Sustainability - Assured - HWE ICB are assured that the provider is positively impacting on the Integrated Care System through their integration and collaboration delivered as a requirement of the specification or alternative elements linked to the delivery. <br/>* Improving Access, Reducing Health Inequalities and Facilitating Choice - Assured - HWE ICB are assured that the provider is meeting needs of the population to ensure equitable access and choice as required by the specification and contract. This criterion was reviewed in line with the Equality Impact Assessment.<br/>* Social Value - Assured - HWE ICB are assured that the provider is delivering in line with the HWE Green Plan, supporting with the implementation of carbon reduction and increase in initiatives which positively impact on the wider determinants of health.<br/><br/>There is currently no alternative local provider for the service and the main benefits include: <br/>* Reducing avoidable A&E attendances and GP appointments and costs associated with these attendances, and potential patient transport costs to attend out of area appointments mainly Royal Free and University College London.<br/>* A locally agreement price for the activity.<br/>* Patient experience and outcomes including self-manage their condition, care closure to home, and seamless care between community, secondary care and primary care.",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-04c7ad",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "SWH - Verulam Chronic Migraine Service 25/27",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85100000",
            "description": "Health services"
        },
        "mainProcurementCategory": "services",
        "description": "The chronic migraine service is provided by Neecare Health Care Ltd<br/>The service undertakes clinical management of chronic migraine for patients who suffer persistent headache.<br/><br/>Neecare chronic migraine service provides clinical intervention for the management of chronic migraine by administering Botulinum injection including regular therapy.<br/><br/>Patients are referred by Neurologist having been diagnosed with Chronic Migraine and meet NICE Guidelines for Botulinum Injection administration.<br/><br/>To confirm, as per the PSR direct award process C, the existing provider is satisfying the existing contract, delivering a good service, meeting all KPIs, with no quality concerns with very good feedback from Clinicians and patients and are likely to satisfy the new contract, The proposed contracting arrangements are not changing from the existing contract.",
        "lots": [
            {
                "id": "1",
                "description": "The Chronic Migraine Clinic provide treatment for patients who suffer from persistence headache of:<br/>* Either tension-type and/or migraine quality and occurs on >=15 days per month for at least 3 months.<br/>* No medication overuse.<br/><br/>A strict referral criterion ensures patients would have to see a Neurologist to be diagnosed with Chronic Migraine and then meets the NICE Guidelines for Botulinum administration.<br/>As such the clinic only accepts referrals from a Neurologist who has diagnosed Chronic Migraine in the patient and who fulfil the NICE criteria. <br/><br/>The clinic maintains close links with the Neurology department at East & North Hertfordshire Trust to receive appropriate support, resources, and education. <br/> <br/>The clinic offers face to face and virtual educational sessions about chronic migraine with clearly defined pathway. <br/><br/>The contract is for one year with option to renew for a further one year based on FOT of PS77, 748. Additional information: The contract is for one year with option to renew for a further one year based on FOT of PS77, 748. From April 2025 to March 2027",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard",
                            "type": "quality",
                            "description": "100"
                        },
                        {
                            "name": "Price",
                            "type": "cost",
                            "description": "0"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "1 year with option to extend for a further 1 year"
                },
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKH23"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_REPETITION_EXISTING",
                "description": "New works/services, constituting a repetition of existing works/services and ordered in accordance with the strict conditions stated in the directive"
            }
        ],
        "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 24/12/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR",
        "amendments": [
            {
                "id": "1",
                "description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C. This contract has now been formally awarded using Direct Award Process CThe contract award date is 27/12/2024 and the standstill period took place between 12th December 2024 to 24th December 2024. The business case including recommendation to award the contract under Provider Selection Process C was approved by the ICB's Strategic Finance and Commissioning Committee on the 22nd of November 2024 and there were no recorded or potential conflicts of Interest of individuals making the decision declared at this meeting. The services is intended to be provided between 1st April 2025 and 31st March 2026 with the contract structured as one year plus an optional one year extension. The maximum value of the new contract is PS77.748 per annum should the optional extension be used, the maximum contract value for the 2 years period is PS155,496."
            }
        ]
    },
    "awards": [
        {
            "id": "040156-2024-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-132667",
                    "name": "Verulam Chronic Migraine Injection Clinic"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-89502",
            "name": "NHS Hertfordshire and West Essex Integrated Care Board",
            "identifier": {
                "legalName": "NHS Hertfordshire and West Essex Integrated Care Board"
            },
            "address": {
                "streetAddress": "Charter House Parkway",
                "locality": "Welwyn Garden City",
                "region": "UKH23",
                "postalCode": "AL8 6JL",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "hweicbhv.procurementteam@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.hertsandwestessex.icb.nhs.uk/",
                "buyerProfile": "https://www.hertsandwestessex.icb.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "REGIONAL_AUTHORITY",
                        "description": "Regional or local authority"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-132667",
            "name": "Verulam Chronic Migraine Injection Clinic",
            "identifier": {
                "legalName": "Verulam Chronic Migraine Injection Clinic"
            },
            "address": {
                "streetAddress": "Neecare Ltd 129 London Road ST Albans United Kingdom",
                "locality": "St Albans",
                "region": "UKH23",
                "postalCode": "AL1 1TA",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-89502",
        "name": "NHS Hertfordshire and West Essex Integrated Care Board"
    },
    "contracts": [
        {
            "id": "040156-2024-1",
            "awardID": "040156-2024-1",
            "status": "active",
            "value": {
                "amount": 155496,
                "currency": "GBP"
            },
            "dateSigned": "2024-12-12T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    },
    "language": "en"
}